Selected Publications

  • Marques P, Menezes MN, Silva GL, Guimarães T, Bernardes A, Cortez-Dias N, Carpinteiro L, Sousa J, Pinto FJ. Triple-site pacing for cardiac resynchronization in permanent atrial fibrillation: follow-up results from a prospective observational study,EP Europace, 2018;20:986–992 view PubMed. Impact factor: 4.521
  • Landmesser U, Chapman MJ, Stock JK, Amarenco P, Belch JJF, Boren J, Farnier M, Ference BA, Gielen S, Graham I, Grobbee DE,, Hovingh GK,, Luscher TF, Piepoli MF, Ray KK, Stroes ES, Wiklund O, Windecker S, Zamorano JL, Pinto F, Tokgozoglu L, Bax JJ, Catapano AL. 2017 Update of ESC/EAS Task Force on practical clinical guidance for proprotein convertase subtilisin/kexin type 9 inhibition in patients with atherosclerotic cardiovascular disease or in familial hypercholesterolaemia. Eur Heart J 2018;39:1131–1143 Impact factor: 20.212
  • Caldeira C, David C, Costa J, Ferreira JJ, Pinto FJ; Non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation and valvular heart disease: systematic review and meta-analysis,   European Heart Journal – Cardiovascular Pharmacotherapy 2018;4:111–118, view PubMed. Impact factor 1.77
  • Fernández-Avilés F, Sanz-Ruiz R, Climent AM, Badimon L, Bolli R, Charron D, Fuster V, Janssens S, Kastrup J, Kim HS, Lüscher TF, Martin JF, Menasché P, Pinto FJ, Simari RD, Stone GW, Terzic A, Willerson JT, Wu JC; TACTICS Writing Group. Global Overview of the Transnational Alliance for Regenerative Therapies in Cardiovascular Syndromes (TACTICS) Recommendations: A Comprehensive Series of Challenges and Priorities of Cardiovascular Regenerative Medicine. Circ Res. 2018;122:199-201 Impact factor: 13.965
  • Graham I, Filippatos G, Atar D, Vardas PE, Pinto FJ, Fitzsimons D. Patient engagement. Eur Heart J. 2017 Nov 7;38(42):3114-3115. Impact factor: 20.212
  • Caldeira D, Rodrigues F, Pinto FJ, Ferreira JJ, Costa J. Thromboprophylaxis With Apixaban in Patients Undergoing Major Orthopedic Surgery: Meta-Analysis and Trial-Sequential Analysis. Clinical Medicine Insights: Blood Disorders 2017;10:1–8.
  • Francisco ARG, Infante de Oliveira E, Nobre Menezes M, Carrilho Ferreira P, Canas da Silva P, Nobre A, Pinto FJ. Combined MitraClip implantation and left atrial appendage occlusion using the Watchman device: A case series from a referral center. Rev Port Cardiol. 2017;36(7-8):525-532.
  • Abreu D, Sousa P, Matias-Dias C, Pinto FJ. “Longitudinal Impact of the Smoking Ban Legislation in Acute Coronary Syndrome Admissions.” Biomed Res International Vol. 2017 Article ID 6956941, 7 pages, 2017. view PubMed.
  • Antman, E. M., J. Bax, R. A. Chazal, M. A. Creager, G. Filippatos, J. L. Halperin, S. Houser, J. Lindenfeld, J. Pinto, P. Vardas, M. N. Walsh, K. A. Williams, Sr. and J. L. Zamorano. “Updated Clinical Practice Guidelines on Heart Failure: An International Alignment.” J Am Coll Cardiol, (2016). view pubMed view doi Impact factor: 17.759 (ePub)
  • Plácido, R., S. R. Martins, P. Canas da Silva, E. Infante de Oliveira, P. Campos, A. G. Almeida and J. Pinto. “St-Segment-Elevation Myocardial Infarction Attributable to Left Main Coronary Artery Compression.” Circulation,133, no. 18 (2016): 1828-9. view pubMed view doi Impact factor:17.202
  • Plácido, R., A. G. Almeida, P. Canas da Silva and Pinto. “Left Main Ostial Agenesis and Right Coronary Artery Occlusion: The Importance of the ‘Vieussens’ Arterial Ring’.” Eur Heart J, (2016). view pubMed view doi Impact factor: 15.064 (ePub)
  • Cowie M. Bax R. J., Bruining N., Cleland J. G., Koehler F., Malik M., Pinto F., van der Velde E., Vardas P. “E-Health: A Position Statement of the European Society of Cardiology” Eur Heart J, 37, no. 1 (2016): 63-66. view pubMed view doi Impact factor: 15.064
  • Arena, R., M. Guazzi, L. Lianov, L. Whitsel, K. Berra, C. J. Lavie, L. Kaminsky, M. Williams, M. F. Hivert, N. Cherie Franklin, J. Myers, D. Dengel, D. M. Lloyd-Jones, J. Pinto, F. Cosentino, M. Halle, S. Gielen, P. Dendale, J. Niebauer, A. Pelliccia, P. Giannuzzi, U. Corra, M. F. Piepoli, G. Guthrie and D. Shurney. “Healthy Lifestyle Interventions to Combat Noncommunicable Disease-a Novel Nonhierarchical Connectivity Model for Key Stakeholders: A Policy Statement from the American Heart Association, European Society of Cardiology, European Association for Cardiovascular Prevention and Rehabilitation, and American College of Preventive Medicine.” Eur Heart J, (2015). view pubMed view doi Impact factor: 15.064
  • Pinto, F., A. G. Fraser, J. Kautzner, K. Kreutzer, S. Piat, M. Siebert, P. Vardas and S. Windecker. “Barriers to Cardiovascular Device Innovation in Europe.” Eur Heart J, (2015). view PubMed view doi Impact factor: 15.064
  • Pinto, F. J. “Integrity and the European Society of Cardiology-Reply.” Lancet , 385, no. 9974 (2015): 1182. view PubMed view doi Impact factor: 44.002
  • Jorge, C., P. Canas da Silva, N. Lousada and J. Pinto. “Effort Syncope and Pencil-Point Left Main Coronary Artery: Cause or Unsual Finding?” Eur Heart J, (2015). view PubMed view doi Impact factor: 15.064
  • Lima da Silva, G., J. Pinto and A. G. Almeida. “Invasive Cardiac Aspergillosis Presenting as Complete Heart Block in a Patient with Acute Lymphoblastic Leukaemia.” Eur Heart J, (2015). view PubMed view doi Impact factor: 15.064
  • Caldeira, D., J. Costa, J. J. Ferreira, G. Y. Lip and J. Pinto. “Non-Vitamin K Antagonist Oral Anticoagulants in the Cardioversion of Patients with Atrial Fibrillation: Systematic Review and Meta-Analysis.” Clin Res Cardiol, (2015). view PubMed view doi Impact factor: 4.324

 

Impact factor de acordo com o 2017 Journal Citation Reports® (Thomson Reuters, 2016).